Study identification

PURI

https://redirect.ema.europa.eu/resource/1000000311

EU PAS number

EUPAS1000000311

Study ID

1000000311

Official title and acronym

Investigating risk of cancer with Sodium-glucose cotransporter 2 inhibitors: a Case/Non-Case Study in the WHO Global Pharmacovigilance Database Vigibase

DARWIN EU® study

No

Study countries

France

Study description

Disproportionnality analysis using the WHO global database Vigibase.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Paul Gautier

Primary lead investigator
ORCID number:
0009-0008-9934-8432
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable